Ikena Oncology

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ikena Oncology and other ETFs, options, and stocks.

About IKNA

Ikena Oncology, Inc. is a clinical stage biotechnology company, which engages in the development of patient directed and biomarker driven therapies for cancer patients. Its product pipeline includes IK-930, RAS Signaling, IK-175, IK-412, and IK-007. 

CEO
Mark Manfredi
CEOMark Manfredi
Employees
10
Employees10
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2016
Founded2016
Employees
10
Employees10

IKNA Key Statistics

Market cap
66.11M
Market cap66.11M
Price-Earnings ratio
-1.59
Price-Earnings ratio-1.59
Dividend yield
—
Dividend yield—
Average volume
100.56K
Average volume100.56K
High today
$1.44
High today$1.44
Low today
$1.35
Low today$1.35
Open price
$1.41
Open price$1.41
Volume
89.22K
Volume89.22K
52 Week high
$1.94
52 Week high$1.94
52 Week low
$0.9707
52 Week low$0.9707

People also own

Based on the portfolios of people who own IKNA. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
Plug Power
Tilray Brands
AMC Entertainment
Lucid Group
Workhorse
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.